Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity.
about
Rho GTPases: Novel Players in the Regulation of the DNA Damage Response?Chemotherapy-Induced Cardiotoxicity: Pathophysiology and PreventionCancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.Differential effects of lovastatin on cisplatin responses in normal human mesothelial cells versus cancer cells: implication for therapy.Cancer metabolism: current perspectives and future directions.Lovastatin prevents bleomycin-induced DNA damage to HepG2 cells.Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions.Rac1 modulates acute and subacute genotoxin-induced hepatic stress responses, fibrosis and liver agingCardiotoxicity of anthracycline therapy: current perspectivesCancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection.Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiationCardio-oncology: cardiovascular complications of cancer therapy.Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.Successful recovery and allogeneic stem cell transplant following chemotherapy-induced severe cardiomyopathy: literature review of management and prognostic factors.Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers.Rac1 signaling protects monocytic AML cells expressing the MLL-AF9 oncogene from caspase-mediated apoptotic death.Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.Rac1 protein signaling is required for DNA damage response stimulated by topoisomerase II poisons.Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts.Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications.Rac1 GTPase, a multifunctional player in the regulation of genotoxic stress response.The decrease of NAD(P)H:quinone oxidoreductase 1 activity and increase of ROS production by NADPH oxidases are early biomarkers in doxorubicin cardiotoxicity.Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation.Mycobacterial Phenolic Glycolipids Selectively Disable TRIF-Dependent TLR4 Signaling in Macrophages.Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology.
P2860
Q26782005-644DF772-9C36-4018-840F-67CD6D31DBF5Q30399577-B9767A76-99DC-4FAD-902C-82E4C8851F5FQ30426853-2538110E-8FB6-46E5-9F12-128CDBBE140AQ34428844-1BE96FD2-4781-45D6-9EA1-E40840C9DBA5Q35723836-DCC3E88D-80D9-426B-ADF0-852755DE0893Q36230902-17E33587-7364-436B-8B80-6BA012A0095FQ36551901-9B309B92-221C-42C0-980C-F7F0A1309496Q36733195-4022410E-9B1D-4E91-9EAE-00E0509C8258Q36845348-F6F9045E-AE82-4B1A-914F-706E04671EAEQ36887091-46F7D0EA-753C-4A60-9FF7-9658A817F3CAQ38546114-6733C12B-C8CF-4EB3-872E-98139261A0E9Q38630699-ACFC4098-D64A-47A6-95C0-9FF85F649F3DQ38665281-809D66B8-B73D-4F4E-B791-5583575B5765Q38678046-225280CD-687A-4BDC-8378-C1BBFF6DA0C6Q38717558-1ABE519E-6EEC-4E1D-A894-55842E2E938DQ39010412-A9874F33-9B73-499F-A6C9-B1F3A023F8CDQ39012650-72D8C986-D28F-49C7-AA09-A5EC6200D68EQ39159284-541BA544-A869-4DAD-846B-9575A1903EE8Q39268019-0D3F4866-B1A0-4798-99C2-7124FEC4777CQ39271267-140275EA-EEBC-413A-BA5A-EE82B80C6F84Q39323215-D66FC994-C290-47C5-8624-794E8632E293Q42632659-72CA4B36-C88B-4401-8856-A0885C99F322Q42790848-73081F16-BC0C-46AB-BCAD-D0B754F4BBD0Q46934674-A0755CEE-429E-4B73-BABD-BFE8DE98D389Q48245077-52AC93B9-659D-4408-BA06-EF78F60A5D4DQ50132332-9BF97196-3A5E-4641-8F23-2359051BB7C9Q51760757-640CA8D2-1300-4F2E-A128-163C8DEF8435Q53661913-0FC5B6BF-7727-461E-9644-7039E2110AF6
P2860
Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Inhibition of Rac1 signaling b ...... line-induced cardiac toxicity.
@en
type
label
Inhibition of Rac1 signaling b ...... line-induced cardiac toxicity.
@en
prefLabel
Inhibition of Rac1 signaling b ...... line-induced cardiac toxicity.
@en
P2093
P2860
P356
P1476
Inhibition of Rac1 signaling b ...... cline-induced cardiac toxicity
@en
P2093
P2860
P356
10.1038/CDDIS.2011.65
P577
2011-08-11T00:00:00Z